Protocols For Health | Sibo-Ease Plus | 120 Capsules

Sibo-Ease Plus | 120 Capsules: Same unique enzyme formulation as Sibo-Ease with the addition of ethylenediaminetetraacetic acid (EDTA) Includes ethylenediaminetetraacetic acid (EDTA) which binds the metals needed for biofilm formation A unique enzyme formulation with EDTA that is especially designed to disrupt the biofilm matrix Developed using in vitro testing...
Title :
-
+
$ 32.00

Protocols For Health

Enzymes

37 In Stock

KINTIP-P

Sibo-Ease Plus | 120 Capsules:

  • Same unique enzyme formulation as Sibo-Ease with the addition of ethylenediaminetetraacetic acid (EDTA)
  • Includes ethylenediaminetetraacetic acid (EDTA) which binds the metals needed for biofilm formation
  • A unique enzyme formulation with EDTA that is especially designed to disrupt the biofilm matrix
  • Developed using in vitro testing of antibiofilm activity and was found to have significant antibiofilm activity

Sibo-Ease Plus provides the same unique enzyme formulation as Sibo-Ease with the addition of ethylenediaminetetraacetic acid (EDTA). The presence of calcium, iron, and magnesium is essential for biofilm creation and serves to cross-link the anionic regions for polymers. Sibo-Ease Plus includes ethylenediaminetetraacetic acid (EDTA) which binds the metals needed for biofilm formation. Biofilm consists of microorganisms encased within a self-produced matrix of exopolysaccharides and exoproteins that strongly adheres to interfaces and resists dislodgement. Microorganisms residing within biofilms are highly resistant to antimicrobials including antibiotics and bacteriocins produced by probiotics.

 

Sibo-Ease Plus is a unique enzyme formulation with EDTA that is especially designed to disrupt the biofilm matrix that embeds potential gastrointestinal pathogens. Enzymes in Sibo-Ease Plus are selected for their ability to lyse the extracellular polymers commonly found in biofilm as well as degrade bacterial and yeast cell wall structures. The enzyme blend in xFEFF; Sibo-Ease Plus was developed using in vitro testing of antibiofilm activity and xFEFF; xFEFF; was found to have significant antibiofilm activity resulting in meaningful degradation of biofilm communities of potentially pathogenic bacteria and yeast. xFEFF; Sibo-Ease Plus is intended for use in conjunction with efforts to support normal gastrointestinal function and microflora. 

 

As an adjunct to other efforts to eliminate potential pathogens, it is best combined with use of a high-potency, broad, multispecies probiotic formulation and a prebiotic to encourage the formation of healthy intestinal microbial biofilm communities. It may also be combined with antimicrobial agents. xFEFF; The capsules should be taken away from meals to maximize the enzyme effects.

Recently Viewed Products